Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2017

Open Access 01-12-2017 | Research

Role of pelvic and para-aortic lymphadenectomy in abandoned radical hysterectomy in cervical cancer

Authors: Salim Abraham Barquet-Muñoz, Gabriel Jaime Rendón-Pereira, Denise Acuña-González, Monica Vanessa Heymann Peñate, Luis Alonso Herrera-Montalvo, Lenny Nadia Gallardo-Alvarado, David Francisco Cantú-de León, René Pareja

Published in: World Journal of Surgical Oncology | Issue 1/2017

Login to get access

Abstract

Background

Cervical cancer (CC) occupies fourth place in cancer incidence and mortality worldwide in women, with 560,505 new cases and 284,923 deaths per year. Approximately, nine of every ten (87%) take place in developing countries. When a macroscopic nodal involvement is discovered during a radical hysterectomy (RH), there is controversy in the literature between resect macroscopic lymph node compromise or abandonment of the surgery and sending the patient for standard chemo-radiotherapy treatment. The objective of this study is to compare the prognosis of patients with CC whom RH was abandoned and bilateral pelvic lymphadenectomy and para-aortic lymphadenectomy was performed with that of patients who were only biopsied or with removal of a suspicious lymph node, treated with concomitant radiotherapy/chemotherapy in the standard manner.

Methods

A descriptive and retrospective study was conducted in two institutions from Mexico and Colombia. Clinical records of patients with early-stage CC programmed for RH with an intraoperative finding of pelvic lymph, para-aortic nodes, or any extracervical involvement that contraindicates the continuation of surgery were obtained. Between January 2007 and December 2012, 42 clinical patients complied with study inclusion criteria and were selected for analysis.

Results

In patients with CC whom RH was abandoned due to lymph node affectation, there is no difference in overall survival or in disease-free period between systematic lymphadenectomy and tumor removal or lymph node biopsy, in pelvic lymph nodes as well as in para-aortic lymph nodes, when these patients receive adjuvant treatment with concomitant radiotherapy/chemotherapy.

Conclusions

This is a hypothesis-generator study; thus, the recommendation is made to conduct randomized prospective studies to procure better knowledge on the impact of bilateral pelvic and para-aortic lymphadenectomy on this group of patients.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase. No. 11 [Internet]. Lyon: Int Agency Res Cancer; 2013. p. 11. http://globocan.iarc.fr. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase. No. 11 [Internet]. Lyon: Int Agency Res Cancer; 2013. p. 11. http://​globocan.​iarc.​fr.
3.
go back to reference Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2006;95(Suppl 1):S43–S103.CrossRefPubMed Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2006;95(Suppl 1):S43–S103.CrossRefPubMed
4.
go back to reference Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical cancer. J Natl Compr Canc Netw. 2013;11:320–43. Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical cancer. J Natl Compr Canc Netw. 2013;11:320–43.
8.
go back to reference Marnitz S, Martus P, Köhler C, et al. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group. Int J Radiat Oncol Biol Phys. 2016;94(2):243–53. doi: 10.1016/j.ijrobp.2015.10.027.CrossRefPubMed Marnitz S, Martus P, Köhler C, et al. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group. Int J Radiat Oncol Biol Phys. 2016;94(2):243–53. doi: 10.​1016/​j.​ijrobp.​2015.​10.​027.CrossRefPubMed
9.
go back to reference Greer B, Koh W, ABU-Rustum N, et al. Cervical cancer. J Natl Compr Netw. 2010;8(12):1388. Greer B, Koh W, ABU-Rustum N, et al. Cervical cancer. J Natl Compr Netw. 2010;8(12):1388.
10.
go back to reference Lee Y, Wang K, Lin M, et al. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases. Gynecol Oncol. 1989;32(2):135.CrossRefPubMed Lee Y, Wang K, Lin M, et al. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases. Gynecol Oncol. 1989;32(2):135.CrossRefPubMed
11.
go back to reference Grisby P, Lu J, Mutch D, Kim R, Eifel PJ. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: phase II study of the Radiation Therapy Oncology Group 92-10. Int J Radiat Oncol Biol Phys. 1998;41(4):817.CrossRef Grisby P, Lu J, Mutch D, Kim R, Eifel PJ. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: phase II study of the Radiation Therapy Oncology Group 92-10. Int J Radiat Oncol Biol Phys. 1998;41(4):817.CrossRef
12.
go back to reference Follen M, Levenback CL, Iyer RB, et al. Imaging in cervical cancer. Cancer. 2003;98(9 Suppl):2028–38.CrossRefPubMed Follen M, Levenback CL, Iyer RB, et al. Imaging in cervical cancer. Cancer. 2003;98(9 Suppl):2028–38.CrossRefPubMed
14.
go back to reference Varia MA, Bundy BN, Deppe G, et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group Study. Int J Radiat Oncol Biol Phys. 1998;42(5):1015–23.CrossRefPubMed Varia MA, Bundy BN, Deppe G, et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group Study. Int J Radiat Oncol Biol Phys. 1998;42(5):1015–23.CrossRefPubMed
15.
go back to reference Lai C-H, Huang K-G, Hong JI-H, et al. Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol. 2003;89(1):160–7.CrossRefPubMed Lai C-H, Huang K-G, Hong JI-H, et al. Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol. 2003;89(1):160–7.CrossRefPubMed
16.
go back to reference Chantalat E, Vidal F, Leguevaque P, et al. Para-aortic workup in locally advanced cervical cancer: heterogeneity is still the rule. Results from a retrospective multicenter study. Arch Gynecol Obstet. 2016;293(5):1081–6. doi: 10.1007/s00404-015-3885-9.CrossRefPubMed Chantalat E, Vidal F, Leguevaque P, et al. Para-aortic workup in locally advanced cervical cancer: heterogeneity is still the rule. Results from a retrospective multicenter study. Arch Gynecol Obstet. 2016;293(5):1081–6. doi: 10.​1007/​s00404-015-3885-9.CrossRefPubMed
Metadata
Title
Role of pelvic and para-aortic lymphadenectomy in abandoned radical hysterectomy in cervical cancer
Authors
Salim Abraham Barquet-Muñoz
Gabriel Jaime Rendón-Pereira
Denise Acuña-González
Monica Vanessa Heymann Peñate
Luis Alonso Herrera-Montalvo
Lenny Nadia Gallardo-Alvarado
David Francisco Cantú-de León
René Pareja
Publication date
01-12-2017
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2017
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-016-1067-2

Other articles of this Issue 1/2017

World Journal of Surgical Oncology 1/2017 Go to the issue